Development and Evaluation of a Prototype of a Novel Clotting Time Test to Monitor Enoxaparin

被引:0
|
作者
Abhishek Gulati
James M. Faed
Geoffrey K. Isbister
Stephen B. Duffull
机构
[1] University of Otago,School of Pharmacy
[2] University of Otago,Department of Pathology, School of Medicine
[3] Calvary Mater Newcastle,Department of Clinical Toxicology and Pharmacology
[4] University of Newcastle,School of Medicine and Public Health
来源
Pharmaceutical Research | 2012年 / 29卷
关键词
coagulation network; enoxaparin; low molecular weight heparins; mathematical model; monitoring;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:225 / 235
页数:10
相关论文
共 50 条
  • [31] USE OF ACTIVATED CLOTTING TIME TO MONITOR ANTICOAGULATION DURING CARDIAC-SURGERY
    NIINIKOSKI, J
    LAATO, M
    LAAKSONEN, V
    JALONEN, J
    INBERG, MV
    SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1984, 18 (01): : 57 - 61
  • [32] Laboratory Evaluation of a Novel Real-Time Respirator Seal Integrity Monitor
    Wu, Bingbing
    Corey, Jonathan
    Yermakov, Michael
    Liu, Yan
    Grinshpun, Sergey A.
    ANNALS OF WORK EXPOSURES AND HEALTH, 2018, 62 (06) : 742 - 753
  • [33] PRELIMINARY EVALUATION OF A NOVEL REAL-TIME BLOOD-GLUCOSE MONITOR
    EDELMAN, SV
    DIABETES, 1994, 43 : A160 - A160
  • [34] Validation of a new point-of-care test to monitor enoxaparin anticoagulation immediately before catheterization
    Silvain, J.
    Beygui, F.
    Bellemain-Appaix, A.
    Pena, A.
    Barthelemy, O.
    Cayla, G.
    Costagliola, D.
    Collet, J. P.
    Montalescot, G.
    EUROPEAN HEART JOURNAL, 2009, 30 : 907 - 908
  • [35] Development and EQ test of the KNICS RPS prototype
    Park, Joo Hyun
    Lee, Dong Yong
    Kim, Chang Hwoi
    2005 IEEE NUCLEAR SCIENCE SYMPOSIUM CONFERENCE RECORD, VOLS 1-5, 2005, : 367 - 370
  • [36] The Shall-Prototype-Test Development Model
    Mrva, M
    Heuchling, M
    Ecker, W
    INTERNATIONAL CONFERENCE AND WORKSHOP ON ENGINEERING OF COMPUTER-BASED SYSTEMS, PROCEEDINGS, 1997, : 385 - 391
  • [37] Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: Results of the STACK-on to ENOXaparin (STACKENOX) study
    Drouet, Ludovic
    Sollier, Claire Bal Dit
    Martin, Jack
    AMERICAN HEART JOURNAL, 2009, 158 (02) : 177 - 184
  • [38] A QUALITY-CONTROL SYSTEM FOR THE ACTIVATED CLOTTING TIME TEST
    SEDOR, FA
    MAYO, E
    KIRVAN, KE
    CLINICAL CHEMISTRY, 1987, 33 (07) : 1261 - 1261
  • [39] Darexaban has high sensitivity in the prothrombin time clotting test
    Funatsu, T.
    Iwatsuki, Y.
    Kaku, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (04) : 703 - 705
  • [40] SHORTENING DEVELOPMENT TIME - IDEA TO PROTOTYPE
    DEGRAVE, C
    MECHANICAL ENGINEERING, 1968, 90 (06) : 73 - &